T/R ratio for estimation of sample size in BE study of NTI drugs [Power / Sample Size]

posted by nobody – 2017-10-26 16:03 (2372 d 17:20 ago) – Posting: # 17921
Views: 6,977

...to be true: I would support discouraging the use of defaults without any knowledge on the actual products (dissolution, pharmaceutical quality etc.). Planning a BE-study should involve that you know that the "correct" GMR / sample size is hindsight knowledge and one way or the other there is a risk to loose money (too many volunteers, too little power to conclude BE), one way ore the other... :-)

Kindest regards, nobody

Complete thread:

UA Flag
Activity
 Admin contact
22,993 posts in 4,828 threads, 1,657 registered users;
97 visitors (0 registered, 97 guests [including 3 identified bots]).
Forum time: 09:23 CEST (Europe/Vienna)

Never never never never use Excel.
Not even for calculation of arithmetic means.    Martin Wolfsegger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5